Project Grant HT94252310527
Award Date 6/15/23
Completion Date 6/14/26
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,477,500 Project Grant to The Schepens Eye Research Institute, Inc., a non-profit organization affiliated with Harvard Medical School and Massachusetts Eye and Ear. The 3-year grant, awarded on September 1, 2023, will fund research on "Topical Calcitonin Gene-Related Peptide for Corneal Injury Prevention and Regeneration." The Schepens Eye Research Institute, which has...
- The Defense Health Agency awarded a $498,896 Project Grant through the Military Medical Research and Development program (CFDA 12.420) to The Schepens Eye Research Institute, Inc. in Boston, MA. The grant supports a 2-year research project investigating the use of noninvasive transpalpebral electrical stimulation as a therapy for combat-related corneal trauma. As an experienced performer of prior federal grants from agencies like the NIH, DoD, and Army, the non-profit Schepens Eye Research...
- The Department of Defense's Defense Health Agency awarded a $820,833 Project Grant to The Schepens Eye Research Institute, Inc., a non-profit research organization affiliated with Harvard Medical School and Massachusetts Eye and Ear. The grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports a research project to "Identify the Liver Microenvironment that Drives Uveal Melanoma Metastasis and Immunity." The 3-year award, effective from...
- The Defense Health Agency awarded a $1,466,706 Project Grant to The Schepens Eye Research Institute, Inc. under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Topical Oxygen for Pan-Ocular Protection (TOPP) Against Severe Chemical Injury." The research aims to develop innovative treatments and medical countermeasures to address vision-related challenges, with a focus on protecting the eye from damage caused by chemical exposures. The...
- The Defense Health Agency awarded a $309,086 Project Grant to the Centre for Eye Research Australia LIMITED, operating as the University of Melbourne Department of Ophthalmology, under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on July 1, 2025, supports a 2-year research project to explore methods for reducing ocular scarring following chemical burns to the eye. The research aims to target NADPH oxidase 4 as a potential approach to mitigate the...
- The Department of the Army Medical Command awarded a $1,428,860 Project Grant to The Schepens Eye Research Institute, Inc. of Boston, MA under the Military Medical Research and Development program (CFDA 12.420) to investigate the safety and efficacy of supersaturated oxygen emulsion (SSOE) as a novel topical treatment for open globe injury. The three-year award beginning September 30, 2022 will support animal research using mice to test SSOE and controls supplied by sub-awardee Coruna Medical...
- The Defense Health Agency awarded a $1,919,965 Project Grant to the Centre for Eye Research Australia Limited, operating as the University of Melbourne Department of Ophthalmology, under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant supports a randomized clinical trial to evaluate an investigational device for retinal thermofusion as a treatment for retinal detachment repair without the use of tamponade. The project aims to develop innovative medical...
- This $1,622,955 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research and development of a novel therapeutic agent called LACRIPEP for corneal wound healing and ocular surface homeostasis. The grant was awarded on September 15, 2024 to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a non-profit research organization, with a performance period ending on September 14,...
- This federal Project Grant award of $540,213.00 from the National Eye Institute (CFDA 93.867 Vision Research) supports research at The Schepens Eye Research Institute, Inc. in Boston, Massachusetts. The research program aims to investigate the mechanisms by which myofibroblasts, cells involved in wound healing, can regulate T cell immune responses and trafficking in corneal transplantation. Specifically, the project will define how myofibroblasts suppress effector T cell activation,...
- This $2,553,092 federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Massachusetts Eye and Ear Infirmary on ex vivo corneal cross-linking for vascularized high-risk keratoplasty (EXCROSSV). The 3-year award, starting August 1, 2024, will enable the Infirmary to conduct this biomedical research study, with Case Western Reserve University serving as a sub-awardee to provide corneal image...